UR Home
Entries of Lubenau, Heinz on the publication server
 | Up a level |
Number of items: 1.
Schmitz-Winnenthal, Friedrich H., Hohmann, Nicolas 
, Schmidt, Thomas , Podola, Lilli, Friedrich, Tobias, Lubenau, Heinz, Springer, Marco, Wieckowski, Sébastien, Breiner, Klaus M., Mikus, Gerd , Büchler, Markus W., Keller, Anne-Valerie, Koc, Ruhan, Springfeld, Christoph , Knebel, Phillip, Bucur, Mariana, Grenacher, Lars, Haefeli, Walter E. and Beckhove, Philipp
(2018)
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer.
OncoImmunology 7 (4), e1303584.
Fulltext not available.
, Schmidt, Thomas , Podola, Lilli, Friedrich, Tobias, Lubenau, Heinz, Springer, Marco, Wieckowski, Sébastien, Breiner, Klaus M., Mikus, Gerd , Büchler, Markus W., Keller, Anne-Valerie, Koc, Ruhan, Springfeld, Christoph , Knebel, Phillip, Bucur, Mariana, Grenacher, Lars, Haefeli, Walter E. and Beckhove, Philipp
(2018)
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer.
OncoImmunology 7 (4), e1303584.
Fulltext not available.
University Library
Publication Server
Contact:
Publishing: oa@ur.de
0941 943 -4239 or -69394
Dissertations: dissertationen@ur.de
0941 943 -3904
Research data: datahub@ur.de
0941 943 -5707